The widely reported difficulties some Americans have encountered accessing the new Covid-19 shots from Pfizer and Moderna may be good news for the drugmakers, despite the troubled rollout.
The level of U.S. demand for the updated boosters, which the CDC on Sept. 12 recommended for everyone over the age of six months, has been a matter of significant debate this year. Moderna (ticker: MRNA) shares are down 44.6% since the start of 2023,
How Ozempic and Wegovy Could Break the System Between cost and demand, the latest breed of weight-loss drugs could transform healthcare in the U.S.—for good and ill.
Between cost and demand, the latest breed of weight-loss drugs could transform healthcare in the U.S.—for good and ill.
JAMES "REV SHARK" DEPORRE
Sep 23, 2023 10:00 AM EDT
Trading in multiple time frames not only reduces risks, but also provides strategic flexibility. Let me show you what I mean and how to do it.